Drug Pipeline

Cell Therapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06096038 Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC Head and Neck Cancer Recruiting
NCT06084884 A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular… Hepatocellular Carcinoma Active, Not Recruiting
Phase 1
NCT04804891 Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in… Intestinal Transplantation Recruiting
NCT07476183 Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent… RPS19 Deficient Diamond-Blackfan Anemia Recruiting
Sponsors Running Cell Therapy Trials
Columbia University (1) AstraZeneca (1) UNC Lineberger Comprehensive Cancer Center (1) Apriligen, Inc. (1)
Disease Areas
Liver Cancer (1) Head & Neck Cancer (1)
Get alerts when Cell Therapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free